feed,title,long_url,short_url
Benzinga,"Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022",https://benzinga.com/general/biotech/21/10/23692840/inventiva-plans-to-start-lanifibranor-combo-study-in-nash-diabetes-in-2022,https://j.mp/3bj2l49
Benzinga,BioMarin's Q3 Net Income Hit By Lower Product Sales,https://benzinga.com/general/biotech/21/10/23691425/biomarins-q3-net-income-hit-by-lower-product-sales,https://j.mp/3ElBVLJ
